Cocrystal of Lutein with Improved Stability and Bioavailability.


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
27 Aug 2024
Historique:
received: 22 04 2024
revised: 28 05 2024
accepted: 30 05 2024
medline: 2 9 2024
pubmed: 2 9 2024
entrez: 2 9 2024
Statut: epublish

Résumé

Lutein (LT) is a natural carotenoid and is widely used for its vision protection and antioxidant activity. However, the long-chain polyene structure makes lutein sensitive to light and oxygen and poses many difficulties in the production, processing, and storage. In addition, the special chemical structure of LT leads to low solubility and bioavailability. In this study, we propose an efficient solution to address these issues. A cocrystal of LT with adipic acid (LT-APC) was obtained for the first time. The cocrystals were fully characterized. After cocrystallization, the melting point of marketed LT was increased. The chemical stability of LT was significantly improved, and the influence of impurities on stability was limited. Dissolution experiments were performed in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) and the cocrystal generated a much higher apparent solubility. To deepen insight into the mechanisms underlying the cocrystal's improved solubility, wettability tests were performed by contact angle determination and film flotation methods. The cocrystal presented better wettability than the marketed LT. Finally, pharmacokinetic studies of marketed LT and its cocrystal were conducted in rats. The results showed that the cocrystal exhibited 3.4 times higher

Identifiants

pubmed: 39220502
doi: 10.1021/acsomega.4c03864
pmc: PMC11359614
doi:

Types de publication

Journal Article

Langues

eng

Pagination

36389-36397

Informations de copyright

© 2024 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Auteurs

Chenxuan Zheng (C)

School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330006, People's Republic of China2.
Pharmaceutical Analytical&Solid-State Chemistry ResearchCenter, Shanghai Institute of Materia Medica, ChineseAcademy of Sciences, Shanghai 201203, People's Republic of China.

Hao Wang (H)

School of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Nan-jing 210023, People's Republic of China.

Ziyao Xiao (Z)

School of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Nan-jing 210023, People's Republic of China.

Zhixiong Sun (Z)

School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330006, People's Republic of China2.
Pharmaceutical Analytical&Solid-State Chemistry ResearchCenter, Shanghai Institute of Materia Medica, ChineseAcademy of Sciences, Shanghai 201203, People's Republic of China.

Junjie Bao (J)

Pharmaceutical Analytical&Solid-State Chemistry ResearchCenter, Shanghai Institute of Materia Medica, ChineseAcademy of Sciences, Shanghai 201203, People's Republic of China.

Wenjuan Dai (W)

Pharmaceutical Analytical&Solid-State Chemistry ResearchCenter, Shanghai Institute of Materia Medica, ChineseAcademy of Sciences, Shanghai 201203, People's Republic of China.

Qi Zhang (Q)

Pharmaceutical Analytical&Solid-State Chemistry ResearchCenter, Shanghai Institute of Materia Medica, ChineseAcademy of Sciences, Shanghai 201203, People's Republic of China.

Xuefeng Mei (X)

School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330006, People's Republic of China2.
Pharmaceutical Analytical&Solid-State Chemistry ResearchCenter, Shanghai Institute of Materia Medica, ChineseAcademy of Sciences, Shanghai 201203, People's Republic of China.
School of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Nan-jing 210023, People's Republic of China.

Classifications MeSH